(2023). Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK. Bmj Open, 13, e068718. http://doi.org/10.1136/bmjopen-2022-068718.
(2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5.
(2022). Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England. Bmc Med, 20, 298. http://doi.org/10.1186/s12916-022-02473-3.
(2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. http://doi.org/10.1038/s41591-022-01909-w.
(2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413.
(2022). Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. Bmc Pregnancy Childbirth, 22, 120. http://doi.org/10.1186/s12884-022-04442-3.